Health·TechCrunch·4d agoGlobal
Efferon NEO Targets Pediatric Sepsis
Device used in 30 countries, FDA filing next
Positive1 min readImportance
AI Summary
Efferon's pediatric blood purification device, Efferon NEO, received a CE mark in April 2026 and is used in ICUs across 30 countries, with the company targeting $2 million in annualized revenue by the end of 2026.
Keywords
pediatric sepsismedical deviceEfferon NEOblood purificationCE mark
